| Stephen Gilles, MSED | |
|
612 S Main Ave, Platte, SD 57369-2117 | |
| (605) 337-2636 | |
| (605) 337-2271 |
| Full Name | Stephen Gilles |
|---|---|
| Gender | Male |
| Speciality | Psychologist - School |
| Location | 612 S Main Ave, Platte, South Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518318914 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TS0200X | Psychologist - School | #055569-01 (South Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Gilles, MSED 612 S Main Ave, P.o. Box 128, Platte, SD 57369-2117 Ph: (605) 337-2636 | Stephen Gilles, MSED 612 S Main Ave, Platte, SD 57369-2117 Ph: (605) 337-2636 |
News Archive
Peter Silverstone knows that, of all his professional accomplishments, none are more important than the work he's doing right now. "I said to my wife that this is probably the most important thing I'll ever do in my life, if I can get this going and make a difference." Silverstone, a professor in the University of Alberta's Department of Psychiatry, is the creator of EMPATHY, a pilot program that has been used in Red Deer Public Schools since 2013 to help lessen incidents of youth anxiety, depression and suicide.
Excelsior Medical Corporation announced today that it has received FDA 510(k) clearance for SwabFlush™, its latest product for the vascular access and infection control markets.
U.S. pediatricians are not using trained language interpreters as often as they should, despite evidence that such services are vital to improving the care of children and families with limited English, according to findings from research conducted jointly by the Johns Hopkins Children's Center and the American Academy of Pediatrics.
Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA therapeutics targeting microRNA-122 in all fields with Hepatitis C Viral infection (HCV) as the lead indication. Under the terms of the new collaboration, Regulus will receive additional upfront and early-stage milestone payments with the potential to earn more than $150 million in miR-122-related combined payments, and tiered royalties up to double digits on worldwide sales of products.
Cameron Health, Inc. today announced the publication of study results online in the New England Journal of Medicine highlighting the development and potential benefits of the company's S-ICD- System, the first minimally invasive, subcutaneous implantable cardioverter defibrillator, for the treatment of sudden cardiac arrest.
› Verified 3 days ago
Mrs. Diane M. Mueller, SCHOOL PSYCHOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 36762 274th Street, Platte, SD 57369 Phone: 605-337-3006 | |
Valerie Johnson, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 612 S Main Ave, Platte, SD 57369 Phone: 605-337-2636 | |
Kristi Kafka, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 612 S Main Ave, Platte, SD 57369 Phone: 605-337-2636 |